Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
4
Halozyme Therapeutics
HALO
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.64%190.23M | -12.88%47.99M | -6.86%37.53M | 4.39%50.98M | 9.25%53.73M | 18.89%193.4M | 31.77%55.08M | 26.91%40.3M | 15.77%48.84M | 4.81%49.18M |
Operating revenue | -1.64%190.23M | -12.88%47.99M | -6.86%37.53M | 4.39%50.98M | 9.25%53.73M | 18.89%193.4M | 31.77%55.08M | 26.91%40.3M | 15.77%48.84M | 4.81%49.18M |
Cost of revenue | 8.58%61.84M | 1.50%16.05M | -0.28%11.08M | 18.70%17.5M | 12.57%17.21M | 14.52%56.95M | 28.42%15.81M | 12.94%11.11M | 9.75%14.74M | 8.04%15.29M |
Gross profit | -5.90%128.39M | -18.67%31.94M | -9.37%26.45M | -1.79%33.49M | 7.75%36.52M | 20.82%136.45M | 33.17%39.27M | 33.18%29.19M | 18.58%34.1M | 3.41%33.89M |
Operating expense | 2.31%198.5M | -2.44%48.24M | -4.68%52.18M | 9.30%48.72M | 9.08%49.37M | -4.77%194.02M | -0.95%49.45M | 10.36%54.74M | -12.19%44.57M | -15.33%45.26M |
Selling and administrative expenses | 2.31%198.5M | -2.44%48.24M | -4.68%52.18M | 9.30%48.72M | 9.08%49.37M | -4.77%194.02M | -0.95%49.45M | 10.36%54.74M | -12.19%44.57M | -15.33%45.26M |
-Selling and marketing expense | 4.64%71.62M | -2.22%18.38M | 5.63%20.32M | 4.56%15.54M | 11.77%17.39M | -7.73%68.45M | 10.36%18.8M | 18.76%19.23M | -17.50%14.86M | -32.19%15.56M |
-General and administrative expense | 1.04%126.88M | -2.57%29.86M | -10.27%31.86M | 11.66%33.18M | 7.66%31.98M | -3.08%125.57M | -6.81%30.65M | 6.28%35.51M | -9.28%29.71M | -2.65%29.7M |
Operating profit | -21.78%-70.11M | -60.22%-16.3M | -0.67%-25.72M | -45.41%-15.23M | -13.04%-12.85M | 36.60%-57.57M | 50.20%-10.18M | 7.71%-25.55M | 52.41%-10.47M | 45.02%-11.37M |
Net non-operating interest income expense | -8.08%3.1M | -37.73%571K | -9.00%768K | 12.26%879K | 6.36%886K | 599.17%3.38M | 97.63%917K | 11,957.14%844K | 15,560.00%783K | 11,800.00%833K |
Non-operating interest income | -8.08%3.1M | -37.73%571K | -9.00%768K | 12.26%879K | 6.36%886K | 599.17%3.38M | 97.63%917K | 11,957.14%844K | 15,560.00%783K | 11,800.00%833K |
Other net income (expense) | 99.83%-23K | -150.00%-15K | -99.34%27K | -100.24%-10K | 99.88%-25K | -150.56%-13.37M | -99.38%30K | 189.30%4.1M | -88.75%4.19M | -96.16%-21.69M |
Gain on sale of security | ---- | ---- | ---- | ---- | ---- | -150.28%-13.39M | --0 | 190.67%4.1M | -88.76%4.2M | -96.36%-21.68M |
Other non- operating income (expenses) | -221.05%-23K | -150.00%-15K | 440.00%27K | -100.00%-10K | -127.27%-25K | 110.38%19K | 188.24%30K | 106.67%5K | 91.23%-5K | 35.29%-11K |
Income before tax | 0.79%-67.03M | -70.63%-15.75M | -20.99%-24.93M | -161.23%-14.36M | 62.79%-11.99M | -5.75%-67.56M | 39.11%-9.23M | 36.16%-20.61M | -135.98%-5.5M | -1.56%-32.23M |
Income tax | 5.50%115K | 108.33%25K | 38.10%29K | -28.30%38K | 0.00%23K | 473.68%109K | 175.00%12K | -4.55%21K | 53K | 76.92%23K |
Net income | 0.78%-67.14M | -70.68%-15.77M | -21.00%-24.96M | -159.42%-14.4M | 62.75%-12.02M | -5.89%-67.67M | 38.97%-9.24M | 36.14%-20.63M | -136.33%-5.55M | -1.59%-32.25M |
Net income continuous Operations | 0.78%-67.14M | -70.68%-15.77M | -21.00%-24.96M | -159.42%-14.4M | 62.75%-12.02M | -5.89%-67.67M | 38.97%-9.24M | 36.14%-20.63M | -136.33%-5.55M | -1.59%-32.25M |
Minority interest income | 10.69%-24.56M | -56.90%-5.63M | -8.66%-9.06M | -135.57%-5.31M | 65.70%-4.57M | 3.56%-27.5M | 44.05%-3.59M | 39.52%-8.34M | -134.21%-2.25M | 10.60%-13.32M |
Net income attributable to the parent company | -6.00%-42.59M | -79.42%-10.15M | -29.37%-15.9M | -175.71%-9.09M | 60.67%-7.45M | -13.49%-40.17M | 35.25%-5.66M | 33.62%-12.29M | -137.93%-3.3M | -12.38%-18.93M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -6.00%-42.59M | -79.42%-10.15M | -29.37%-15.9M | -175.71%-9.09M | 60.67%-7.45M | -13.49%-40.17M | 35.25%-5.66M | 33.62%-12.29M | -137.93%-3.3M | -12.38%-18.93M |
Basic earnings per share | 7.32%-0.38 | -125.00%-0.09 | -7.69%-0.14 | -166.67%-0.08 | 66.67%-0.07 | 0.00%-0.41 | 60.00%-0.04 | 38.10%-0.13 | -130.00%-0.03 | 0.00%-0.21 |
Diluted earnings per share | 7.32%-0.38 | -125.00%-0.09 | -7.69%-0.14 | -166.67%-0.08 | 66.67%-0.07 | 0.00%-0.41 | 60.00%-0.04 | 38.10%-0.13 | -133.33%-0.03 | 0.00%-0.21 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |